As expected, Jak2V617F Flex/WT VE-cadherin-Cre-ERT2 (herein referred to as Jak2V617F EC) mice did not develop MPN (Figure 2, A–D). This evidence concerns the gene MAPK3 and myeloproliferative neoplasm.